OpenAI chief executive Sam Altman says two emerging risk fronts may define the next phase of AI.
In a new interview with Axios, Altman says the ChatGPT creator is keeping a close watch on cybersecurity and biology as domains where AI capabilities are advancing rapidly.
According to Altman, improvements in AI models mean that bad actors will likely use the technology to mount a serious attack.
“The main areas we currently track in our preparedness framework are cybersecurity and bio… I suspect in the next year, we will see significant threats that we have to mitigate from cyber, and these models are already quite capable and will get much more capable.”
Looking at biology, Altman says the same systems driving progress could also introduce new vulnerabilities.
“And then on bio… the models are clearly going to get very good at helping people do biology at an advanced level. Wonderful things are going to happen there. We will see a bunch of diseases get cured. Someone is going to try to misuse those…”
According to the OpenAI executive, AI models in the hands of the wrong people could trigger a catastrophic event.
“We are not that far away from a world where there are incredibly capable open-source models that are very good at biology and the need for society to be resilient to terrorist groups using these models to try to create novel pathogens. That’s no longer a theoretical thing, or it’s not going to be for much longer.”
Disclaimer: Opinions expressed at CapitalAI Daily are not investment advice. Investors should do their own due diligence before making any decisions involving securities, cryptocurrencies, or digital assets. Your transfers and trades are at your own risk, and any losses you may incur are your responsibility. CapitalAI Daily does not recommend the buying or selling of any assets, nor is CapitalAI Daily an investment advisor. See our Editorial Standards and Terms of Use.